Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of β-thalassemia.
Matte A, Federti E, Winter M, Koerner A, Harmeier A, Mazer N, Tomka T, Di Paolo ML, De Falco L, Andolfo I, Beneduce E, Iolascon A, Macias-Garcia A, Chen JJ, Janin A, Lebouef C, Turrini F, Brugnara C, De Franceschi L.
Matte A, et al. Among authors: brugnara c.
JCI Insight. 2019 Nov 14;4(22):e130111. doi: 10.1172/jci.insight.130111.
JCI Insight. 2019.
PMID: 31593554
Free PMC article.